Identification of new DNA gyrase inhibitors based on bioactive compounds from streptomyces: structure-based virtual screening and molecular dynamics simulations approaches

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1, 19–25. doi:10.1016/j.softx.2015.06.001
   Google Scholar
• Al-Nadaf, A. H., Salah, S. A., & Taha, M. O. (2018). Discovery of new Gyrase β inhibitors via structure based modeling. Computational Biology and Chemistry, 74, 263–272. doi:10.1016/j.compbiolchem.2018.03.020
   PubMed Web of Science ®Google Scholar
• Backman, T. W., Cao, Y., & Girke, T. (2011). ChemMine tools: An online service for analyzing and clustering small molecules. Nucleic Acids Research, 39(suppl_2), W486–W497. doi:10.1093/nar/gkr320
   PubMed Web of Science ®Google Scholar
• Berjanskii, M., Liang, Y., Zhou, J., Tang, P., Stothard, P., Zhou, Y., … Lu, P. (2010). PROSESS: A protein structure evaluation suite and server. Nucleic Acids Research, 38(suppl_2), W633–W640. doi:10.1093/nar/gkq375
   PubMed Web of Science ®Google Scholar
• Cheng, P., Li, J., Wang, J., Zhang, X., & Zhai, H. (2018). Investigations of FAK inhibitors: A combination of 3D-QSAR, docking, and molecular dynamics simulations studies. Journal of Biomolecular Structure and Dynamics, 36(6), 1529–1549. doi:10.1080/07391102.2017.1329095
   PubMed Web of Science ®Google Scholar
• Collin, F., Karkare, S., & Maxwell, A. (2011). Exploiting bacterial DNA gyrase as a drug target: Current state and perspectives. Applied Microbiology and Biotechnology, 92(3), 479–497. doi:10.1007/s00253-011-3557-z
   PubMed Web of Science ®Google Scholar
• Dahlin, J. L., Nissink, J. W. M., Strasser, J. M., Francis, S., Higgins, L., Zhou, H., … Walters, M. A. (2015). PAINS in the assay: Chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS. Journal of Medicinal Chemistry, 58(5), 2091–2113. doi:10.1021/jm5019093
   PubMed Web of Science ®Google Scholar
• de Freitas, R. F., & Schapira, M. (2017). A systematic analysis of atomic protein–ligand interactions in the PDB. MedChemComm, 8(10), 1970–1981. doi:10.1039/C7MD00381A
   PubMed Web of Science ®Google Scholar
• DeLano, W. L. (2002). The PyMOL molecular graphics system to bedside: Structure-based drug design on protein targets. Current Pharmaceutical Design, 18(9), 1217–1239. doi:10.3390/molecules200713384
   Web of Science ®Google Scholar
• Drlica, K., & Malik, M. (2003). Fluoroquinolones: Action and resistance. Current Topics in Medicinal Chemistry, 3(3), 249–282. doi:10.2174/1568026033452537
   PubMed Web of Science ®Google Scholar
• Edwards, M. J., Flatman, R. H., Mitchenall, L. A., Stevenson, C. E., Le, T. B., Clarke, T. A., … Lawson, D. M. (2009). A crystal structure of the bifunctional antibiotic simocyclinone D8, bound to DNA gyrase. Science, 326(5958), 1415–1418. doi:10.1126/science.1179123
   PubMed Web of Science ®Google Scholar
• Fuglebakk, E., Echave, J., & Reuter, N. (2012). Measuring and comparing structural fluctuation patterns in large protein datasets. Bioinformatics, 28(19), 2431–2440. doi:10.1093/bioinformatics/bts445
   PubMed Web of Science ®Google Scholar
• Hearnshaw, S. J., Edwards, M. J., Stevenson, C. E., Lawson, D. M., & Maxwell, A. (2014). A new crystal structure of the bifunctional antibiotic simocyclinone D8 bound to DNA gyrase gives fresh insight into the mechanism of inhibition. Journal of Molecular Biology, 426(10), 2023–2033. doi:10.1016/j.jmb.2014.02.017
   PubMed Web of Science ®Google Scholar
• Heide, L. (2014). New aminocoumarin antibiotics as gyrase inhibitors. International Journal of Medical Microbiology, 304(1), 31–36. doi:10.1016/j.ijmm.2013.08.013
   PubMed Web of Science ®Google Scholar
• Heo, L., Park, H., & Seok, C. (2013). GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Research, 41(W1), W384–W388. doi:10.1093/nar/gkt458
   PubMed Web of Science ®Google Scholar
• Hertweck, C., Luzhetskyy, A., Rebets, Y., & Bechthold, A. (2007). Type II polyketide synthases: Gaining a deeper insight into enzymatic teamwork. Natural Product Reports, 24(1), 162–190. doi:10.1039/B507395M
   PubMed Web of Science ®Google Scholar
• Jagadeb, M., Rath, S. N., & Sonawane, A. (2018). In silico discovery of potential drug molecules to improve the treatment of isoniazid-resistant Mycobacterium tuberculosis. Journal of Biomolecular Structure and Dynamics, 1–11. doi:10.1080/07391102.2018.1515116
   PubMed Web of Science ®Google Scholar
• Khan, T., Sankhe, K., Suvarna, V., Sherje, A., Patel, K., & Dravyakar, B. (2018). DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. Biomedicine & Pharmacotherapy, 103, 923–938. doi:10.1016/j.biopha.2018.04.021
   PubMed Web of Science ®Google Scholar
• Kim, J.-Y., Kim, S.-H., Jeon, S.-M., Park, M.-S., Rhie, H.-G., & Lee, B.-K. (2008). Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea. Clinical Microbiology and Infection, 14(8), 760–765. doi:10.1111/j.1469-0691.2008.02033.x
   PubMed Web of Science ®Google Scholar
• Kim, J., Jeon, S., Kim, H., Park, M., Kim, S., & Kim, S. (2012). Multiplex real-time polymerase chain reaction-based method for the rapid detection of gyrA and parC mutations in quinolone-resistant Escherichia coli and Shigella spp. Osong Public Health and Research Perspectives, 3(2), 113–117. doi:10.1016/j.phrp.2012.04.004
   PubMedGoogle Scholar
• Klementz, D., Döring, K., Lucas, X., Telukunta, K. K., Erxleben, A., Deubel, D., … Bechthold, A. (2015). StreptomeDB 2.0—An extended resource of natural products produced by streptomycetes. Nucleic Acids Research, 44(D1), D509–D514. doi:10.1093/nar/gkv1319
   PubMed Web of Science ®Google Scholar
• Koes, D. R., Baumgartner, M. P., & Camacho, C. J. (2013). Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. Journal of Chemical Information and Modeling, 53(8), 1893–1904. doi:10.1021/ci300604z
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., Consortium, O. S. D. D., & Lynn, A. (2014). g_mmpbsa. A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. doi:10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A. (2008). PDBsum new things. Nucleic Acids Research, 37(suppl_1), D355–D359. doi:10.1093/nar/gkn860
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. doi:10.1107/S0021889892009944
   Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand–protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. doi:10.1021/ci200227u
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17. doi:10.1016/j.addr.2012.09.019
   Web of Science ®Google Scholar
• Lobanov, M. Y., Bogatyreva, N., & Galzitskaya, O. (2008). Radius of gyration as an indicator of protein structure compactness. Molecular Biology, 42(4), 623–628. doi:10.1134/S0026893308040195
   Web of Science ®Google Scholar
• Lucas, X., Senger, C., Erxleben, A., Grüning, B. A., Döring, K., Mosch, J., … Günther, S. (2012). StreptomeDB: A resource for natural compounds isolated from Streptomyces species. Nucleic Acids Research, 41(D1), D1130–D1136. doi:10.1093/nar/gks1253
   PubMed Web of Science ®Google Scholar
• Madurga, S., Sánchez‐Céspedes, J., Belda, I., Vila, J., & Giralt, E. (2008). Mechanism of binding of fluoroquinolones to the quinolone resistance‐determining region of DNA gyrase: Towards an understanding of the molecular basis of quinolone resistance. Chembiochem, 9(13), 2081–2086. doi:10.1002/cbic.200800041
   PubMed Web of Science ®Google Scholar
• Malathi, K., Anbarasu, A., & Ramaiah, S. (2019). Identification of potential inhibitors for Klebsiella pneumoniae carbapenemase-3: A molecular docking and dynamics study. Journal of Biomolecular Structure and Dynamics, 1–13. doi:10.1080/07391102.2018.1556737
   PubMed Web of Science ®Google Scholar
• Maxwell, A. (1997). DNA gyrase as a drug target. Trends in Microbiology, 5(3), 102–109. doi:10.1016/S0966-842X(96)10085-8
   PubMed Web of Science ®Google Scholar
• Monhemi, H., Housaindokht, M. R., Moosavi-Movahedi, A. A., & Bozorgmehr, M. R. (2014). How a protein can remain stable in a solvent with high content of urea: Insights from molecular dynamics simulation of Candida antarctica lipase B in urea: Choline chloride deep eutectic solvent. Physical Chemistry Chemical Physics, 16(28), 14882–14893. doi:10.1039/c4cp00503a
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. doi:10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Mulvey, M. R., & Simor, A. E. (2009). Antimicrobial resistance in hospitals: How concerned should we be? Canadian Medical Association Journal, 180(4), 408–415. doi:10.1503/cmaj.080239
   PubMed Web of Science ®Google Scholar
• Narayana, K. J., Prabhakar, P., Vijayalakshmi, M., Venkateswarlu, Y., & Krishna, P. S. (2008). Study on bioactive compounds from Streptomyces sp. ANU 6277. Polish Journal of Microbiology, 57(1), 35–39. PMID:18610654
   PubMed Web of Science ®Google Scholar
• Newman, M. J., Frimpong, E., Donkor, E. S., Opintan, J. A., & Asamoah-Adu, A. (2011) Resistance to antimicrobial drugs in Ghana. Infection and Drug Resistance, 4, 215–220. doi:10.2147/IDR.S21769
   PubMedGoogle Scholar
• O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 33. doi:10.1186/1758-2946-3-33
   PubMed Web of Science ®Google Scholar
• Oppegard, L. M., Hamann, B. L., Streck, K. R., Ellis, K. C., Fiedler, H.-P., Khodursky, A. B., & Hiasa, H. (2009). In vivo and in vitro patterns of the activity of simocyclinone D8, an angucyclinone antibiotic from Streptomyces antibioticus. Antimicrobial Agents and Chemotherapy, 53(5), 2110–2119. doi:10.1128/AAC.01440-08
   PubMed Web of Science ®Google Scholar
• Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 9(58), 4066–4072. doi:10.1021/acs.jmedchem.5b00104
   Web of Science ®Google Scholar
• Pu, X.-Y., Zhang, Q., Pan, J.-C., Shen, Z., & Zhang, W. (2013). Spontaneous mutation frequency and molecular mechanisms of Shigella flexneri fluoroquinolone resistance under antibiotic selective stress. World Journal of Microbiology and Biotechnology, 29(2), 365–371. doi:10.1007/s11274-012-1190-3
   PubMed Web of Science ®Google Scholar
• Pushie, M. J., & George, G. N. (2010). Active-site dynamics and large-scale domain motions of sulfite oxidase: A molecular dynamics study. The Journal of Physical Chemistry B, 114(9), pp. 3266–3275 . doi:10.1021/jp908731f
   PubMed Web of Science ®Google Scholar
• Qian-Cutrone, J., Kolb, J. M., McBrien, K., Huang, S., Gustavson, D., Lowe, S. E., & Manly, S. P. (1998). Quanolirones I and II, two new human cytomegalovirus protease inhibitors produced by Streptomyces sp. WC76535. Journal of Natural Products, 61(11), 1379–1382 doi:10.1021/np980234k
   PubMed Web of Science ®Google Scholar
• Rahimi, H., Najafi, A., Eslami, H., Negahdari, B., & Moghaddam, M. M. (2016). Identification of novel bacterial DNA gyrase inhibitors: An in silico study. Research in Pharmaceutical Sciences, 11(3), 250–258. PMID:27499795
   PubMed Web of Science ®Google Scholar
• Rejwan Ali, M., Sadoqi, M., Boutajangout, A., & Mezei, M. (2019). Virtual screening of a natural compound library at orthosteric and allosteric binding sites of the neurotensin receptor. Journal of Biomolecular Structure and Dynamics, 1–13. doi:10.1080/07391102.2018.1552200
   Web of Science ®Google Scholar
• Roggo, S. (2007). Natural products in drug discovery. CHIMIA, 61(6), 312. 2007.312. doi:10.2533/chimia
   Web of Science ®Google Scholar
• Ruiz, J. (2003). Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection. Journal of Antimicrobial Chemotherapy, 51(5), 1109–1117. doi:10.1093/jac/dkg222
   PubMed Web of Science ®Google Scholar
• Sadiq, A. A., Patel, M. R., Jacobson, B. A., Escobedo, M., Ellis, K., Oppegard, L. M., … Kratzke, R. A. (2010). Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II. Investigational New Drugs, 28(1), 20–25. doi:10.1007/s10637-008-9209-1
   PubMed Web of Science ®Google Scholar
• Samorlu, A. S., Yelekçi, K., & Ibrahim Uba, A. (2019). The design of potent HIV-1 integrase inhibitors by a combined approach of structure-based virtual screening and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 1–7. doi:10.1080/07391102.2018.1557559
   Web of Science ®Google Scholar
• Sander, T., Freyss, J., von Korff, M., & Rufener, C. (2015). DataWarrior: An open-source program for chemistry aware data visualization and analysis. Journal of Chemical Information and Modeling, 55(2), 460–473. doi:10.1021/ci500588j
   PubMed Web of Science ®Google Scholar
• Schüttelkopf, A. W., & Van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallographica Section D: Biological Crystallography, 60(8), 1355–1363. doi:10.1107/S0907444904011679
   PubMedGoogle Scholar
• Shen, B. (2003). Polyketide biosynthesis beyond the type I, II and III polyketide synthase paradigms. Current Opinion in Chemical Biology, 7(2), 285–295. doi:10.1016/S1367-5931(03)00020-6
   PubMed Web of Science ®Google Scholar
• Sherer, B. A., Hull, K., Green, O., Basarab, G., Hauck, S., Hill, P., … Bryant, J. (2011). Pyrrolamide DNA gyrase inhibitors: Optimization of antibacterial activity and efficacy. Bioorganic and Medicinal Chemistry Letters, 21(24), 7416–7420. doi:10.1016/j.bmcl.2011.10.010
   PubMed Web of Science ®Google Scholar
• Shiri, F., Pirhadi, S., & Ghasemi, J. B. (2018). Dynamic structure based pharmacophore modeling of the acetylcholinesterase reveals several potential inhibitors. Journal of Biomolecular Structure and Dynamics, 1–13. doi:10.1080/07391102.2018.1468281
   PubMed Web of Science ®Google Scholar
• Shiri, F., Pirhadi, S., & Rahmani, A. (2018). Identification of new potential HIV-1 reverse transcriptase inhibitors by QSAR modeling and structure-based virtual screening. Journal of Receptors and Signal Transduction, 38(1), 37–47. doi:10.1080/10799893.2017.1414844
   PubMed Web of Science ®Google Scholar
• Simmerling, C., Strockbine, B., & Roitberg, A. E. (2002). All-atom structure prediction and folding simulations of a stable protein. Journal of the American Chemical Society, 124(38), 11258–11259. doi:10.1021/ja0273851
   PubMed Web of Science ®Google Scholar
• Varughese, L. R., Rajpoot, M., Goyal, S., Mehra, R., Chhokar, V., & Beniwal, V. (2018). Analytical profiling of mutations in quinolone resistance determining region of gyrA gene among UPEC. PLoS One, 13(1),e. 0190729. doi:10.1371/journal.pone.0190729
   Web of Science ®Google Scholar
• Verghese, J., Nguyen, T., Oppegard, L. M., Seivert, L. M., Hiasa, H., & Ellis, K. C. (2013). Flavone-based analogues inspired by the natural product simocyclinone D8 as DNA gyrase inhibitors. Bioorganic & Medicinal Chemistry Letters, 23(21), 5874–5877. doi:10.1016/j.bmcl.2013.08.094
   PubMed Web of Science ®Google Scholar
• Webb, B., & Sali, A. (2014). Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics, 47(1), 5.6.1–5.6.32. doi:10.1002/0471250953.bi0506s47
   Google Scholar
• Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(suppl_2), W407–W410. doi:10.1093/nar/gkm290
   PubMed Web of Science ®Google Scholar
• Williams, M., & Ladbury, J. (2008). Hydrogen bonds in protein‐ligand complexes. Protein Science Encyclopedia: Online, 137–161. doi:10.1002/9783527610754.pl02
   Google Scholar
• Zhou, H., Wang, C., Deng, T., Tao, R., & Li, W. (2018). Novel urushiol derivatives as HDAC8 inhibitors: Rational design, virtual screening, molecular docking and molecular dynamics studies. Journal of Biomolecular Structure and Dynamics, 36(8), 1966–1978. doi:10.1080/07391102.2017.1344568
   PubMed Web of Science ®Google Scholar